The introduction of biosimilars has significantly altered the landscape of biologic drug distribution models. Biosimilars, which are highly similar to […]
The impact of biosimilars on biologic drug distribution models Read Post »
In a seismic shift for European intellectual property, the Unified Patent Court (UPC) is rapidly transforming how businesses approach patent
Unified Patent Court Reshapes European Patent Landscape Read Post »
To find low-competition generic drug opportunities, focus on drugs with limited competition due to small patient populations, complex formulations, or
How to find low-competition generic drug opportunities Read Post »
The integration of artificial intelligence (AI) into drug discovery and development is revolutionizing the pharmaceutical industry. AI’s ability to analyze
Patenting Drugs Developed with Artificial Intelligence: Navigating the Legal Landscape Read Post »
China is emerging as a global frontrunner in patenting artificial intelligence (AI) technologies for drug discovery, particularly in the field
The pharmaceutical industry is a high-stakes arena where innovation, investment, and intellectual property (IP) protection intersect. One of the most
The Power of Patience: Delaying Patents to Enhance Pharma Market Exclusivity Read Post »
Lipitor’s marketing strategy underwent a significant evolution as generic competition emerged, employing aggressive tactics to retain market share and brand
How can pharmaceutical marketing evolve with generic entry? The example of Lipitor Read Post »
Patent Expirations and Generic Competition This week saw several major blockbuster drugs facing patent expirations, potentially opening the market for
Introduction Patent portfolios are critical assets for pharmaceutical companies, providing market exclusivity and protecting revenue streams for drug products. Effective
Best Practices for Drug Patent Portfolio Management Read Post »
Get fresh news and insights, drug patent expirations & more…
